QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 0.501
-- x --
-- x --
-- - --
$ 0.50 - $ 0.84
948
na
na
$ -0.96
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cannabis-slowdown-in-canada-analyst-spotlights-what-still-sells-and-where-the-money-is-going

In a recent report, Pablo Zuanic of Zuanic & Associates analyzed trends in Canada's recreational cannabis market throug...

 cannara-biotech-reports-51-yoy-revenue-increase-in-q2-wider-net-loss

Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-m...

Core News & Articles

GAINERS: EVIO (OTC:EVIO) shares closed up 100.00% at $0.0001

Core News & Articles

GAINERS: Hemp (OTC:HEMP) shares closed up 50.00% at $0.00015

 cannara-biotech-q3-fy23-net-revenue-grows-57-yoy-what-about-adjusted-ebitda

Cannara Biotech Inc.

Core News & Articles

GAINERS: EVIO (OTC:EVIO) shares closed up 4900.00% at $5e-05

 cannara-biotech-secures-an-additional-10m-in-non-dilutive-capital-with-its-lead-credit-provider--bmo-commercial-banking

Cannara Biotech Inc.

 cannara-biotech-q2-fy23-revenue-grows-76-yoy-to-96m-here-are-the-details

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) released its fiscal second quarter 2023 financial results, revealing ...

 olymbec-investments-increases-its-ownership-in-cannara-biotech

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) held its annual shareholder meeting on January 25, 2023.

 cannara-biotech-q1-revenue-grows-57-yoy-to-77m-what-about-adjusted-ebitda

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) released its fiscal first quarter 2023 financial results for the thr...

 cannara-biotech-q4-revenue-grows-84-yoy-to-89m

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) released its fiscal fourth quarter and fiscal year 2022 financial res...

 cannara-biotech-enters-into-the-british-columbia-cannabis-market-and-launches-new-products

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB), a Quebec-based, vertically integrated producer of cannabis and deriv...

 cannara-biotech-signs-an-exclusive-brand-partnership-with-exotic-genetix-in-canada

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) entered into an exclusive brand partnership with Exotic Genetix Ltd.

 cannara-biotech-revenue-grows-41-yoy-here-are-the-details

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) fiscal Q3 2022 revenue was $10.1 million, a 36% increase from the pre...

 cannara-biotech-closes-50-million-credit-facility-led-by-bmo-commercial-banking

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) has closed on a $50M credit facility led by BMO Commercial Banking.

 cannara-biotech-revenues-grew-229-to-74m-in-q2-2022-yoy

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) released its fiscal second quarter 2022 financial and operating resu...

 the-week-in-cannabis-isiah-thomas-tilray-the-dea-ohio-mexico-and-more

Below is a recap of the main news related to the cannabis industry and markets for the week of December 6, 2021. Contents